- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (27)
1 result(s) found for: 2019-002328-33.
Displaying page 1 of 1.
EudraCT Number: 2019-002328-33 | Sponsor Protocol Number: VB_C-02 | Start Date*: 2020-02-07 | |||||||||||
Sponsor Name:Nykode Therapeutics ASA | |||||||||||||
Full Title: A Multi-Centre, Open-label Phase 2a Trial of the Combination of VB10.16 and Atezolizumab in Patients with Advanced or Recurrent, Non-resectable HPV16-Positive Cervical Cancer | |||||||||||||
Medical condition: Advanced or recurrent non-resectable HPV16-positive cervical cancer, who failed or are not eligible for current standard of care | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) NO (Completed) BG (Completed) CZ (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
